JPRN-jRCTs032230015
Recruiting
Phase 2
Percutaneous Cryoablation under Local Anesthesia for Thoracic Malignancies study - Coolest study
Asakura Keisuke0 sites20 target enrollmentStarted: April 10, 2023Last updated:
ConditionsThoracic Malignancies
Overview
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Asakura Keisuke
- Enrollment
- 20
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 18age old to <= 79age old (—)
- Sex
- All
Inclusion Criteria
- •Eligible patients for this study must meet all of the following criteria:
- •1\) Thoracic Malignancies (with metastatic disease previously confirmed by prior biopsy or known (biopsied) primary disease): Patient with Stage4 pulmonary metastatic disease, Patient with recurrence tumor (primary lung cancer, malignant mediastinal tumor, malignant pleural tumor, malignant chest wall tumor) after the initial treatment.
- •2\) Thoracic Malignancies without adaptation for the standard treatment: Patient who are not tolerable for surgery, Patient without adaptation for the radiotherapy because of the tumor location or the tumor with overlapping irradiation fields and retreating local progression after previous radiotherapy, Patient with tumor ineffective to radiotherapy and chemotherapy.
- •3\) Patient has up to 3 tumors targetable by cryoablation.
- •4\) Maximum size of tumor(s):Targeted tumor(s) defined as intrapulmonary with a maximum size of 3\.5 cm, Targeted tumor(s) defined as mediastinal or pleural or chest wall with a maximum size of 10\.0 cm.
- •5\) Patient without uncontrollable primary or metastatic disease other than targeted tumor(s).
- •6\) Patient must be 18 years or older, 79 years or younger.
- •7\) ECOG performance status of 0\-2\.
- •8\) Patients who are judged eligible for cryoablation by the interventional radiologists in charge of cryoablation, the thoracic surgeons in charge of cryoablation and surgery, the radiotherapists in charge of radiotherapy, and the pulmonologists in charge of chemotherapy.
- •9\) The target tumor is determined to be technically achievable by the interventional radiologists in charge of cryoablation.
Exclusion Criteria
- •Patients not eligible for participation in this study include patients who have any of the following:
- •1\) INR \> 1\.5 or platelet count \< 50,000/mm3 within 28 days prior to registration.
- •2\) Patient has had chemotherapy with neutropenia to levels (ANC \< 1000/mm3\) within 28 days prior to registration.
- •3\) Patient has uncontrolled coagulopathy or bleeding disorders.
- •4\) Patient has evidence of active systemic, pulmonary, or pericardial infection.
- •5\) Patient is unable to lie flat.
- •6\) Patient has respiratory distress at rest.
- •7\) Patient with pregnancy.
- •8\) Patient with active interstitial pneumonia.
- •9\) Patients who are judged ineligible by the doctor in charge.
Investigators
Similar Trials
Completed
Phase 2
Safety and Efficacy of Percutaneous Cryoablation for Thoracic MalignanciesPrimary lung cancer, metastatic lung cancer, mediastinal tumor, chest wall tumorJPRN-UMIN000014996School of Medicine, Keio University200
Completed
Not Applicable
CRYO-SCAR studyesophageal cancerJPRN-jRCT1080225331ational Cancer Center Hospital East15
Completed
Phase 1
Phase 1 Clinical Trial of Percutaneous Cryoablation for Painful Musculoskeletal TumorPainful Muscloskeletal tumor (osteoid osteoma, metastatic MSK tumor)JPRN-UMIN000027828Gunma University Hospital18
Recruiting
Phase 3
Efficacy of local anesthesia with cold therapy in pain control during filling of damaged teethHealth Condition 1: K004- Disturbances in tooth formationCTRI/2024/04/066002Dr Faizal CP
Not yet recruiting
Not Applicable
Safety and feasibility of the use of cryoablation in patients with brain neoplasmbrain neoplasmbrain tumors1002765610019190NL-OMON53649Erasmus MC, Universitair Medisch Centrum Rotterdam30